CURIS, INC. Increase (Decrease) in Deferred Revenue
CURIS, INC. (CRIS) reported Increase (Decrease) in Deferred Revenue of -$475.83 thousand for the 12-month period ending 2010-12-31, per its 10-K filed 2013-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2013-03-13
- CURIS, INC. increase (decrease) in deferred revenue for the quarter ending 2010-12-31 was $0.00.
- CURIS, INC. increase (decrease) in deferred revenue for the quarter ending 2010-09-30 was $0.00.
- CURIS, INC. increase (decrease) in deferred revenue for fiscal 2010 was -$475.83K, a 200.00% decline from fiscal 2009.
- CURIS, INC. increase (decrease) in deferred revenue for fiscal 2009 was $475.83K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | $0.00 derived: sum of 2 quarters · filed 2013-03-13 | -$475.83K 10-K · filed 2013-03-13 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | -$475.83K 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | -$475.83K 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $475.83K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |